4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD Berberine plus lifestyle intervention, Placebo plus lifestyle intervention - Obesity, Obesity, Abdominal | Phase 4 | Completed | China National Center for Cardiovascular Diseases | 337 | 2023-07-06 | 2025-01-29 |
| Probiotic Supplementation IN NAFLD Patients Control Test - NAFLD | Phase 4 | Completed | Ain Shams University | 50 | 2021-09-12 | 2023-10-10 |
| Follow-up of NAFLD Patients With MRI-PDFF Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG - Diabetes Type 2, NAFLD | Phase 4 | Completed | Asmaa Abdelfattah Elsayed | 80 | 2020-12-01 | 2022-12-20 |
| Effect of Obesity on Proton Pump Inhibitors Lansoprazole, Pantoprazole, Midazolam - Pediatric Obesity, NAFLD | Phase 4 | Completed | Children's Mercy Hospital Kansas City | 76 | 2018-07-03 | 2026-06-04 |
Non-alcoholic Fatty Liver Disease (4) · Diabetes Mellitus, Type 2 (1) · Gastroesophageal Reflux (1) · Obesity (1) · Obesity, Abdominal (1) · Pediatric Obesity (1)
Digestive System Diseases (4) · Fatty Liver (4) · Liver Diseases (4) · Nutritional and Metabolic Diseases (3) · Body Weight (2) · Nutrition Disorders (2) · Overnutrition (2) · Overweight (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Deglutition Disorders (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1)
Berberine (1) · Lansoprazole (1) · Midazolam (1) · Pantoprazole (1) · Pentoxifylline (1) · Ursodeoxycholic Acid (1) · empagliflozin (1)
Ain Shams University (1) · Asmaa Abdelfattah Elsayed (1) · Children's Mercy Hospital Kansas City (1) · China National Center for Cardiovascular Diseases (1)
Egypt (2) · China (1) · United States (1)
Asmaa A Elsayed, PhD (1) · Haibo Zhang, MD (1) · Jing Li, PhD (1) · Kathryn Kyler, MD, MS (1)
K23DK115827 (1)